1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67845DA12FB382584002588000064EA0D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medical-affairs-resource-allocation-to-support-high-functioning-medical-operations?opendocument
18
19opendocument
2018.208.186.139
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Structure, Staffing and Budgets

Medical Affairs Resource Allocation to Support High-Functioning Medical Operations

ID: 5719


Features:

2 Info Graphics

9 Data Graphics

60 Metrics

2 Narratives


Pages/Slides: 17


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical Affairs Resource Allocation to Support High-Functioning Medical Operations”

STUDY OVERVIEW

Medical Affairs continues to be one of the fastest growing functions in pharma as organizations use its medical expertise to leverage successful product launches and to improve market access.


However, some organizations are struggling to ascertain how much they should be investing in Medical Affairs and its varied roles.

Best Practices, LLC conducted this research to inform medical leaders on how their peers have increased/decreased medical spend, how much are organizations funding each of the roles within medical and how medical's budget has changed since 2020.


This short study will help guide medical leaders in their budget deliberations.

KEY TOPICS

  • Medical Affairs: Spend Change
  • Medical Affairs: Spending Allocation

SAMPLE KEY METRICS

  • How has your medical affairs spending changed since the year 2020?
  • Please describe the key reasons for any decreases in spending that you indicated in the question above.
  • By what percentage has the medical affairs spend increased?
  • Please describe the key reasons for any increase in spending that you indicated in the question above.
  • What percentage of the total Medical Affairs spend (above) was allocated to each of the following functions in the most recently completed fiscal year?
  • For the therapeutic areas and geographic areas you indicated, what percentage of your Medical Affairs spending is allocated into these activities?
  • Actual budget change from 2020 to 2021 :What changes have you experienced in budget levels between the past and current fiscal years (2020 to 2021) and what change level do you anticipate between the current year and 2022?

SAMPLE KEY FINDINGS

  • Medical Budgets Growing: Nearly half of the respondents have increased medical affairs spend since 2020

METHODOLOGY

This study engages 20 executives from leading life sciences companies.

Industries Profiled:
Pharmaceutical; Consumer Products; Biotech; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Novartis; Annexon Biosciences; Fidia; CMR Surgical; Sandoz; Novavax; Pixacore; Arcutis Biotherapeutics; Eisai; Fibrogen; Biohaven Pharmaceuticals; Horizon Therapeutics; Takeda Pharmaceuticals; Terumo Corporation; Sanofi; Teleflex; Eurofarma; Becton Dickinson; ASC Therapeutics

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.